A structurally tuned HPV cancer SNA vaccine boosts CD8⁺ T‑cell responses and slows tumor growth in mice and patient‑derived spheroids, a study shows.
Explore how HPV tumours are targeted by innovative vaccine designs that enhance immune response against cancer effectively.
WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced today that it has received Good Manufacturing ...
Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: ...
If proven effective in humans, the vaccine could complement standard therapies for HPV-driven cancer, as well as inform the ...
The findings will be published today (February 11) in Science Advances.
Throughout the past decade, Northwestern University scientists have uncovered a striking principle of vaccine design: ...
CD Bioparticles launches specialized RNA Synthesis services for researchers to develop next-generation mRNA vaccines, gene therapies, and RNA-based therapeutics.
Albrecht Kossel's Nobel Prize-winning research unveiled the chemical basis of heredity, shaping modern genetics and molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results